Discover the detailed record of transactions filed by Nicholson Nur, Chief Technical Officer. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 6 disclosures have been recorded. The latest transaction was disclosed on 28 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.